UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination

Psychopharmacology, 2013-04, Vol.226 (3), p.615-622

2013

Volltextzugriff (PDF)

Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications

Comprehensive psychiatry, 2012-07, Vol.53 (5), p.480-483

2012

Volltextzugriff (PDF)

Machine learning fMRI classifier delineates subgroups of schizophrenia patients

Schizophrenia research, 2014-12, Vol.160 (1), p.196-200

2014

Volltextzugriff (PDF)

Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity

Schizophrenia research, 2012-02, Vol.134 (2), p.131-136

2012

Volltextzugriff (PDF)

Global functional connectivity deficits in schizophrenia depend on behavioral state

The Journal of neuroscience, 2011-09, Vol.31 (36), p.12972-12981

2011

Volltextzugriff (PDF)

Distinct Response Inhibition Patterns in Obsessive Compulsive Disorder Patients and Pathological Gamblers

Frontiers in psychiatry, 2018-12, Vol.9, p.652-652

2018

Volltextzugriff (PDF)

Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition

European neuropsychopharmacology, 2008-06, Vol.18 (6), p.431-438

2008

Volltextzugriff (PDF)

Effects of psychotropic drugs on cell proliferation and differentiation

Biochemical pharmacology, 1999-10, Vol.58 (8), p.1229-1236

1999

Volltextzugriff (PDF)

Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study

Journal of clinical psychopharmacology, 2003-06, Vol.23 (3), p.305-308

2003

Volltextzugriff (PDF)

Israeli Preschool Children Under Scuds: A 30-Month Follow-up

Journal of the American Academy of Child and Adolescent Psychiatry, 1997-03, Vol.36 (3), p.349-356

1997

Volltextzugriff (PDF)

The antinociceptive properties of reboxetine in acute pain

European neuropsychopharmacology, 2009-10, Vol.19 (10), p.735-739

2009

Volltextzugriff (PDF)

Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

Pharmacogenomics, 2000-08, Vol.1 (3), p.335-341

2000

Volltextzugriff (PDF)

Correlation of Suicidal and Violent Behavior in Different Diagnostic Categories in Hospitalized Adolescent Patients

Journal of the American Academy of Child and Adolescent Psychiatry, 1995-07, Vol.34 (7), p.912-918

1995

Volltextzugriff (PDF)

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

European journal of pharmacology, 1996-02, Vol.298 (1), p.27-30

1996

Volltextzugriff (PDF)

Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder

Psychiatry research, 2012-05, Vol.197 (1), p.19-22

2012

Volltextzugriff (PDF)

Effects of Peripheral-type Benzodiazepine Receptor Antisense Knockout on MA-10 Leydig Cell Proliferation and Steroidogenesis

The Journal of biological chemistry, 1998-03, Vol.273 (10), p.5478-5483

1998

Volltextzugriff (PDF)

Obsessive-compulsive disorder in schizophrenia: Clinical characteristics and treatment

CNS drugs, 2004-01, Vol.18 (14), p.989-1010

2004

Volltextzugriff (PDF)

Low-Dose Mirtazapine: A New Option in the Treatment of Antipsychotic-Induced Akathisia. A Randomized, Double-Blind, Placebo- and Propranolol-Controlled Trial

Biological psychiatry (1969), 2006-06, Vol.59 (11), p.1071-1077

2006

Volltextzugriff (PDF)

Memantine for Treatment-Resistant OCD

The American journal of psychiatry, 2005-11, Vol.162 (11), p.2191-a-2192

2005

Volltextzugriff (PDF)

Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor

Journal of neurochemistry, 1992-05, Vol.58 (5), p.1589-1601

1992

Volltextzugriff (PDF)

Cytokine production in major depressed patients before and after clomipramine treatment

Biological psychiatry (1969), 1994, Vol.35 (1), p.42-47

1994

Volltextzugriff (PDF)

Aripiprazole's Receptor Pharmacology and Extrapyramidal Side Effects

The American journal of psychiatry, 2008-03, Vol.165 (3), p.398-398

2008

Volltextzugriff (PDF)

Mirtazapine – A Multifunctional Drug: Low Dose for Akathisia

CNS spectrums, 2011-02, Vol.16 (2), p.63-63

2011

Volltextzugriff (PDF)

Does co-morbid obsessive-compulsive disorder modify the abnormal language processing in schizophrenia patients? An FMRI study

Frontiers in human neuroscience, 2014-07, Vol.8, p.560-560

2014

Volltextzugriff (PDF)

Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetineâ[euro]"betahistine combination

Psychopharmacology, 2013-04, Vol.226 (3), p.615

2013

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Englisch
(169)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(128)
Science & Technology
(128)
Male
(113)
Humans
(100)
Biological And Medical Sciences
(96)
Female
(82)
Medical Sciences
(82)
Psychiatry
(76)
Neurosciences & Neurology
(64)
Psychology. Psychoanalysis. Psychiatry
(64)
Adult
(51)
Neurosciences
(49)
Animals
(43)
Psychopathology. Psychiatry
(43)
Pharmacology & Pharmacy
(38)
Pharmacology. Drug Treatments
(35)
Adult And Adolescent Clinical Studies
(34)
Middle Aged
(34)
Adolescent
(30)
Neuropharmacology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination

Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications

Machine learning fMRI classifier delineates subgroups of schizophrenia patients

Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity

Global functional connectivity deficits in schizophrenia depend on behavioral state

Distinct Response Inhibition Patterns in Obsessive Compulsive Disorder Patients and Pathological Gamblers

Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition

Effects of psychotropic drugs on cell proliferation and differentiation

Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study

Israeli Preschool Children Under Scuds: A 30-Month Follow-up

The antinociceptive properties of reboxetine in acute pain

Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

Correlation of Suicidal and Violent Behavior in Different Diagnostic Categories in Hospitalized Adolescent Patients

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter

Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder

Effects of Peripheral-type Benzodiazepine Receptor Antisense Knockout on MA-10 Leydig Cell Proliferation and Steroidogenesis

Obsessive-compulsive disorder in schizophrenia: Clinical characteristics and treatment

Low-Dose Mirtazapine: A New Option in the Treatment of Antipsychotic-Induced Akathisia. A Randomized, Double-Blind, Placebo- and Propranolol-Controlled Trial

Memantine for Treatment-Resistant OCD

Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor

Cytokine production in major depressed patients before and after clomipramine treatment

Aripiprazole's Receptor Pharmacology and Extrapyramidal Side Effects

Mirtazapine – A Multifunctional Drug: Low Dose for Akathisia

Does co-morbid obsessive-compulsive disorder modify the abnormal language processing in schizophrenia patients? An FMRI study

Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetineâ[euro]"betahistine combination

Suchergebnisse filtern